Alliance for Clinical Trials in Oncology
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
- Conditions
- Interventions
- First Posted Date
- 2008-04-02
- Last Posted Date
- 2021-08-18
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 717
- Registration Number
- NCT00651261
- Locations
- 🇺🇸
St. Luke's Regional Medical Center, Sioux City, Iowa, United States
🇺🇸Ministry Saint Clare's Hospital, Weston, Wisconsin, United States
🇺🇸Cancer Centers of the Carolinas - Easley, Easley, South Carolina, United States
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
- Conditions
- Interventions
- First Posted Date
- 2008-03-11
- Last Posted Date
- 2023-06-12
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 731
- Registration Number
- NCT00632853
- Locations
- 🇺🇸
Saint Mary Corwin Medical Center, Pueblo, Colorado, United States
🇺🇸NorthShore University HealthSystem-Glenbrook Hospital, Glenview, Illinois, United States
🇺🇸Illinois CancerCare-Princeton, Princeton, Illinois, United States
Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery
- Conditions
- Interventions
- First Posted Date
- 2008-02-29
- Last Posted Date
- 2018-05-01
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 95
- Registration Number
- NCT00626405
- Locations
- 🇺🇸
Swedish Medical Center, Englewood, Colorado, United States
🇺🇸Perry Memorial Hospital, Princeton, Illinois, United States
🇺🇸St. James Healthcare Cancer Care, Butte, Montana, United States
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
- Conditions
- Interventions
- First Posted Date
- 2008-02-22
- Last Posted Date
- 2018-05-08
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 54
- Registration Number
- NCT00621686
- Locations
- 🇺🇸
Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
🇺🇸Cancer Care Associates, Fresno, California, United States
🇺🇸Front Range Cancer Specialists, Fort Collins, Colorado, United States
Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery
- Conditions
- Interventions
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2017-04-05
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 52
- Registration Number
- NCT00601627
- Locations
- 🇺🇸
Great Falls Clinic - Main Facility, Great Falls, Montana, United States
🇺🇸Mid Dakota Clinic, PC, Bismarck, North Dakota, United States
🇺🇸Illinois CancerCare - Canton, Canton, Illinois, United States
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
- Conditions
- Interventions
- First Posted Date
- 2008-01-09
- Last Posted Date
- 2017-04-05
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 5
- Registration Number
- NCT00588900
- Locations
- 🇺🇸
Cancer Resource Center - Lincoln, Lincoln, Nebraska, United States
🇺🇸Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana, United States
🇺🇸CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States
Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer
- Conditions
- Interventions
- First Posted Date
- 2007-12-12
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Registration Number
- NCT00571740
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- First Posted Date
- 2007-11-15
- Last Posted Date
- 2021-08-18
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 318
- Registration Number
- NCT00558519
Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
- Conditions
- Interventions
- First Posted Date
- 2007-11-04
- Last Posted Date
- 2020-02-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 122
- Registration Number
- NCT00553150
- Locations
- 🇺🇸
Park Nicollet Cancer Center, Saint Louis Park, Minnesota, United States
🇺🇸Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
🇺🇸Mayo Clinic - Jacksonville, Jacksonville, Florida, United States
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
- Conditions
- Interventions
- First Posted Date
- 2007-11-04
- Last Posted Date
- 2018-01-31
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 78
- Registration Number
- NCT00553462
- Locations
- 🇺🇸
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center, Hartford, Connecticut, United States
🇺🇸Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States
🇺🇸Heartland Regional Medical Center, Saint Joseph, Missouri, United States